Clinical Trials Directory

Trials / Conditions / Invasive Ductal Breast Cancer

Invasive Ductal Breast Cancer

9 registered clinical trials studyying Invasive Ductal Breast Cancer.

StatusTrialSponsorPhase
UnknownImage-guided Targeted Doxorubicin Delivery With Hyperthermia to Optimize Loco-regional Control in Breast Cance
NCT03749850
UMC UtrechtPhase 1
CompletedDenosumab as an add-on Neoadjuvant Treatment (GeparX)
NCT02682693
GBG Forschungs GmbHPhase 2
CompletedA Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treat
NCT02125344
GBG Forschungs GmbHPhase 3
UnknownTrial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Respo
NCT02879513
RenJi HospitalPhase 3
Active Not RecruitingWeekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients
NCT02221999
RenJi HospitalPhase 2 / Phase 3
WithdrawnLumpectomy Followed By Intraoperative Electron Radiation Therapy (IOERT)
NCT01960803
Wake Forest University Health SciencesN/A
CompletedAddition of Cisplatin to Neoadjuvant Therapy for T Locally Advanced Breast Cancer
NCT02199418
RenJi HospitalPhase 2
CompletedNanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast
NCT01583426
GBG Forschungs GmbHPhase 3
CompletedAddition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer
NCT01426880
GBG Forschungs GmbHPhase 2 / Phase 3